Pediatrix Medical Group (NYSE:MD) Shares Gap Up – Here’s Why

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) gapped up before the market opened on Monday . The stock had previously closed at $12.44, but opened at $13.18. Pediatrix Medical Group shares last traded at $12.98, with a volume of 35,468 shares traded.

Wall Street Analyst Weigh In

A number of research firms recently commented on MD. Macquarie started coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company. Truist Financial decreased their target price on Pediatrix Medical Group from $16.00 to $15.00 and set a “hold” rating for the company in a research report on Monday, January 6th. UBS Group upped their price target on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Thursday. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $16.25.

Pediatrix Medical Group Price Performance

The company has a market capitalization of $1.11 billion, a P/E ratio of -4.22, a PEG ratio of 2.00 and a beta of 1.58. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. The business has a 50 day simple moving average of $14.30 and a 200-day simple moving average of $11.62.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm had revenue of $511.20 million for the quarter, compared to the consensus estimate of $498.87 million. During the same period last year, the firm posted $0.29 EPS. Pediatrix Medical Group’s quarterly revenue was up .9% compared to the same quarter last year. Analysts predict that Pediatrix Medical Group, Inc. will post 1.26 EPS for the current fiscal year.

Insider Buying and Selling

In other Pediatrix Medical Group news, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the transaction, the executive vice president now owns 135,810 shares of the company’s stock, valued at approximately $2,172,960. This represents a 5.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total value of $423,660.00. Following the completion of the transaction, the director now owns 138,683 shares in the company, valued at $2,128,784.05. The trade was a 16.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MD. Texas Permanent School Fund Corp grew its position in Pediatrix Medical Group by 29.6% in the second quarter. Texas Permanent School Fund Corp now owns 93,367 shares of the company’s stock worth $705,000 after acquiring an additional 21,351 shares in the last quarter. American Century Companies Inc. increased its position in Pediatrix Medical Group by 13.7% during the second quarter. American Century Companies Inc. now owns 124,395 shares of the company’s stock worth $939,000 after buying an additional 15,023 shares during the last quarter. WINTON GROUP Ltd lifted its position in shares of Pediatrix Medical Group by 33.9% in the second quarter. WINTON GROUP Ltd now owns 130,491 shares of the company’s stock worth $985,000 after buying an additional 33,057 shares during the last quarter. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $81,000. Finally, Hsbc Holdings PLC raised its stake in shares of Pediatrix Medical Group by 29.3% in the 2nd quarter. Hsbc Holdings PLC now owns 30,502 shares of the company’s stock valued at $227,000 after acquiring an additional 6,921 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.